CA2042534A1 - Treatment and/or a Method of Treating - Google Patents

Treatment and/or a Method of Treating

Info

Publication number
CA2042534A1
CA2042534A1 CA2042534A CA2042534A CA2042534A1 CA 2042534 A1 CA2042534 A1 CA 2042534A1 CA 2042534 A CA2042534 A CA 2042534A CA 2042534 A CA2042534 A CA 2042534A CA 2042534 A1 CA2042534 A1 CA 2042534A1
Authority
CA
Canada
Prior art keywords
treatment
treating
viral infections
equine viral
caffeine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2042534A
Other languages
French (fr)
Other versions
CA2042534C (en
Inventor
Oswald Edmonds Hooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ23132289A external-priority patent/NZ231322A/en
Priority claimed from NZ23397390A external-priority patent/NZ233973A/en
Priority to AU65875/90A priority Critical patent/AU642173B2/en
Priority to GB9110413A priority patent/GB2255718B/en
Priority to CA002042534A priority patent/CA2042534C/en
Application filed by Individual filed Critical Individual
Priority to JP3205011A priority patent/JP2731051B2/en
Priority to US07/895,236 priority patent/US5275828A/en
Publication of CA2042534A1 publication Critical patent/CA2042534A1/en
Publication of CA2042534C publication Critical patent/CA2042534C/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a treatment for equine viral infections which includes potassium iodide, ammonium chloride and caffeine. A method of treating equine viral infections is also provided which involves administering the composition daily.
CA002042534A 1989-11-08 1991-05-14 Treatment and/or a method of treating Expired - Fee Related CA2042534C (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU65875/90A AU642173B2 (en) 1989-11-08 1990-11-07 Improvements in or relating to a treatment and or a method of treating
GB9110413A GB2255718B (en) 1989-11-08 1991-05-14 Pharmaceutical composition for treating bacterial and / or viral infection
CA002042534A CA2042534C (en) 1989-11-08 1991-05-14 Treatment and/or a method of treating
JP3205011A JP2731051B2 (en) 1989-11-08 1991-05-15 Pharmaceutical composition for equine virus infection and method of treating the same
US07/895,236 US5275828A (en) 1989-11-08 1992-06-08 Treatment and/or a method of treating equine viral and bacterial infections

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NZ23132289A NZ231322A (en) 1989-11-08 1989-11-08 Treatment of viral and/or bacterial infections
NZ23397390A NZ233973A (en) 1989-11-08 1990-06-07 Treatment of viral and/or bacterial infections
CA002042534A CA2042534C (en) 1989-11-08 1991-05-14 Treatment and/or a method of treating
JP3205011A JP2731051B2 (en) 1989-11-08 1991-05-15 Pharmaceutical composition for equine virus infection and method of treating the same

Publications (2)

Publication Number Publication Date
CA2042534A1 true CA2042534A1 (en) 1992-11-15
CA2042534C CA2042534C (en) 1996-11-12

Family

ID=27426852

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002042534A Expired - Fee Related CA2042534C (en) 1989-11-08 1991-05-14 Treatment and/or a method of treating

Country Status (4)

Country Link
JP (1) JP2731051B2 (en)
AU (1) AU642173B2 (en)
CA (1) CA2042534C (en)
GB (1) GB2255718B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996032952A1 (en) * 1995-04-21 1996-10-24 Oswald Edmonds Hooper Caffeine composition as medicament and use thereof
WO1999011276A1 (en) * 1997-09-02 1999-03-11 Oswald Edmonds Hooper Medicament including potassium iodide and ammonium chloride
US20100266573A1 (en) * 2007-11-23 2010-10-21 Pharmalundensis Ab Method and means for obtaining bronchorelaxation
US8840934B2 (en) * 2009-01-02 2014-09-23 Rainbow Pharmaceutical Sa Uses of ammonium chloride

Also Published As

Publication number Publication date
AU642173B2 (en) 1993-10-14
GB9110413D0 (en) 1991-07-03
JPH05112457A (en) 1993-05-07
GB2255718A (en) 1992-11-18
GB2255718B (en) 1995-05-10
JP2731051B2 (en) 1998-03-25
CA2042534C (en) 1996-11-12
AU6587590A (en) 1991-05-16

Similar Documents

Publication Publication Date Title
CA2213339A1 (en) Method of treating adenosine depletion
GB8821049D0 (en) Method & composition for treatment & prevention of viral infections
AR240251A1 (en) METHOD TO PREPARE A COMPOSITION FOR TREATMENT OF VIRAL INFECTIONS AND A METHOD TO SYNTHESIZE 3 'AZIDO 2', 3 'DIDEOXIURIDINA INTENDED FOR THE PREPARATION OF SUCH COMPOSITION.
EP0509019A4 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
LTIP919A (en) Drugs and process for preparing thereof
OA08581A (en) Treatment of diseases caused by retroviruses.
FI891338A (en) Improvement of the process for the preparation of 2 ', 3'-dideoxy-2', 3'-didehydronucleosides
CA2024188A1 (en) Method of treating premature ejaculation using sertraline
EP0251434A3 (en) Treatment of fungal infections
AU1331588A (en) Method for treatment of alcohol abuse
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
LTIP863A (en) Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases
PT86362A (en) Process for the preparation of anxiolytic compositions containing n-(1-azabicyclo ]2,2.2."-oct-3-yl) benzamides and thiobenzamides
NL960024I1 (en) Pharmaceutical composition comprising 3'-deoxythymidine-2'-ene (3'-deoxy-2 ', 3'-didehydrothymidine) for the treatment of retrovirus-stained patients.
ZA902754B (en) Concentrated aqueous solution of glutaraldehyde and 1,2-benzisothiazolin-3-one
EP0608212A4 (en) Method of treating viral infection.
AU587706B2 (en) Process for the recovery of ammonia and fluoride values from ammonium fluoride solutions
CA2042534A1 (en) Treatment and/or a Method of Treating
EP0264744A3 (en) Process for the preparation of 4,4'-diaminodiphenylmethane and its derivatives.
PT87004A (en) PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS AND COMPOSITES 3'-AZIDE-2 ', 3'-DIDESOXY-IN OSINE AND 3'-FLUORO-2', 3'-DIDESOXYGUANOSINE
EP0273310A3 (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
CA2138793A1 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
YU222189A (en) 2-azabicyclo (2.2.1) hept-5-en-2-ocetic acid, it's derivatives and familiar compounds, process for obtaining those compounds and use for obtaining n- phosphono-methylglycine
EP0235904A3 (en) Treatment of allergy with thymopentin
AU3881889A (en) Human interferon-gamma, process to prepare said human interferon-gamma, and its use

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed